EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model

Jonas Rusnak iD, Victoria Delcheva iD, Dirk Theile, Antje Blank, Norbert Frey, Michael R Preusch iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0349211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Jonas Rusnak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Pneumology, Heidelberg University, Medical Faculty Heidelberg/Heidelberg University Hospital Internal Medicin…. Hauptthemen laut MEDLINE: Atherosclerosis, Apolipoproteins E. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maxwell Biotech Group, Bundesministerium für Bildung und Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Bile acids are known to have a positive impact on atherosclerosis. The study investigates the impact of sodium taurocholate co-transporting polypeptide (NTCP) inhibition with bulevirtide, organic anion transporting polypeptide (OATP) inhibition with rifampicin, and their combination on bile acid levels and atherosclerosis in apolipoprotein E–deficient (ApoE⁻/⁻) mice.

Methods

Fifty-six female ApoE⁻/⁻ mice on a Western type diet were treated daily for four weeks with bulevirtide (5 mg/kg), rifampicin (20 mg/kg), a combination of both, or vehicle. Plasma bile acids and lipids were measured at sacrifice. Atherosclerotic lesion size was quantified in the aortic sinus, and macrophage content was analyzed by Mac-2 immunohistochemistry.

Results

Plasma cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglyceride levels remained unchanged across all groups, being accompanied with no changes of atherosclerotic lesion size (p = 0.896). However, treatment with bulevirtide (p = 0.017), rifampicin (p = 0.003), but mostly their combination (p < 0.001) significantly increased plasma bile acid concentrations and altered the macrophage-to-lesion area ratio, at least for the combination therapy group (p = 0.020). The combined treatment exhibited the highest bile acid levels, indicating additive effects of dual transporter inhibition.

Conclusions

While lesion sizes remained unaffected, the combined NTCP and OATP inhibition significantly enhanced bile acid levels and reduced macrophage content in early atherosclerotic lesions of ApoE⁻/⁻ mice. These results highlight the association of bile acid with the modulation of plaque composition as a potential therapeutic mode of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisApolipoproteins EAnimalsFemaleMiceDisease Models, AnimalBile Acids and SaltsRifampinMacrophagesOrganic Anion Transporters, Sodium-DependentSymportersMice, Knockout

Substanzen

Apolipoproteins EBile Acids and Saltssodium-bile acid cotransporterRifampinOrganic Anion Transporters, Sodium-DependentSymporters

Autor:innen und Institutionen

  • Department of Cardiology, Angiology and Pneumology, Heidelberg University, Medical Faculty Heidelberg/Heidelberg University Hospital Internal Medicine III, Heidelberg, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.
  • Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, Medical Faculty Heidelberg/Heidelberg University Hospital Internal Medicine IX, Heidelberg, Germany.
  • DZIF (German Center for Infection Research), Partner Site Heidelberg, Heidelberg, Germany.

ORCID-Profile: Jonas Rusnak, Victoria Delcheva, Michael R Preusch

Förderung

  • Maxwell Biotech Group
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Rusnak, J., Delcheva, V., Theile, D., Blank, A., Frey, N., & Preusch, M. R. (2026). Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model. PLOS One. https://doi.org/10.1371/journal.pone.0349211

Vancouver

Rusnak J, Delcheva V, Theile D, Blank A, Frey N, Preusch MR. Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model. PLOS One. 2026. doi:10.1371/journal.pone.0349211

BibTeX
@article{Rusnak2026,
  author = {Rusnak, Jonas and Delcheva, Victoria and Theile, Dirk and Blank, Antje and Frey, Norbert and Preusch, Michael R},
  title = {Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0349211}
}
Kostenlos starten →